Kenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...

This new class of GLP-1 weight loss drugs may feel like a miracle, but it still takes effort from you for these meds to work safely and effectively.

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.

Navvi, the cash‑pay digital prescribing platform founded by physicians, today announced the launch of its All‑Specialty Compound Medication Marketplace and a formal call for additional accredited ...

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Engineers at Georgia Tech developed a new mode of delivery for injectable medications — an 'exploding' capsule.

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street.However, the company ...

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...

GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in ...